Abstract
Refractory anemia (RA) in myelodysplastic syndromes (MDS) are very heterogeneous diseases regarding their morphology, clinical features and survival. We proposed the new designations ‘RA with severe dysplasia (RASD)’ and ‘RA with minimal dysplasia (RAminiD)’. In our criteria, RASD is considered present if a bone marrow (BM) examination shows Pseudo-Pelger–Huet anomalies of mature neutrophils ⩾3% and/or micromegakaryocytes (mMgk) of megakaryocytes ⩾10% in RA patients. RAminiD is defined as RA cases other than RASD. After the reclassification of 58 primary RA patients, the group was composed of 45 RAminiD and 13 RASD patients. The blast percentage in the BM and the frequency of cytogenetic abnormalities observed in the RASD patients were intermediate between those in the RAminiD and RAEB patients. The analysis of survival curves revealed differences among the three groups; the RASD patients had lower survival probabilities than those of the RAminiD group, and significantly higher probabilities than those of the RAEB group. (RAminiD vs RASD, P = 0.06; RASD vs RAEB, P = 0.004.) Our data indicate that in RA patients, RASD is a distinct subset of RA with an unfavorable clinical outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuda, A., Jinnai, I., Yagasaki, F. et al. Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia. Leukemia 12, 482–485 (1998). https://doi.org/10.1038/sj.leu.2400966
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400966
Keywords
This article is cited by
-
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
Experimental Hematology & Oncology (2015)
-
Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization
International Journal of Hematology (2015)
-
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Annals of Hematology (2015)
-
The Search for Better Prognostic Models in Myelodysplastic Syndromes
Current Hematologic Malignancy Reports (2011)
-
Myelodysplastic syndrome: classification and prognostic systems
Oncology Reviews (2010)